Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • SGLT2 Inhibitors and GLP-1 Ago...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes

Bibliographic Details
Published in:Diabetes & Metabolism Journal
Main Author: Jae-Han Jeon
Format: Article
Language:English
Published: Korean Diabetes Association 2024-03-01
Online Access:http://e-dmj.org/upload/pdf/dmj-2024-0079.pdf
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://e-dmj.org/upload/pdf/dmj-2024-0079.pdf

Similar Items

  • SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
    by: Jae Hyun Bae
    Published: (2025-05-01)
  • SGLT-2 Inhibitors’ and GLP-1 Receptor Agonists’ Influence on Neuronal and Glial Damage in Experimental Stroke
    by: Anna Murasheva, et al.
    Published: (2024-12-01)
  • SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
    by: Christopher El Mouhayyar, et al.
    Published: (2020-01-01)
  • SGLT2 inhibitors and GLP-1 receptor agonists: impact on mortality in diabetic patients with cardiovascular disease
    by: Ziad Arow, et al.
    Published: (2025-08-01)
  • SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome
    by: Aryan Gajjar, et al.
    Published: (2025-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs